Prosight Management, LP has filed its 13F form on November 14, 2024 for Q3 2024 where it was disclosed a total value porftolio of $372 Million distributed in 47 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Adc Therapeutics Sa with a value of $30.4M, Galapagos Nv with a value of $29.6M, Bridge Bio Pharma, Inc. with a value of $27.7M, Ab Cellera Biologics Inc. with a value of $23.5M, and Meira G Tx Holdings PLC with a value of $20.4M.
Examining the 13F form we can see an increase of $52.2M in the current position value, from $320M to 372M.
Prosight Management, LP is based out at Dallas, TX
Below you can find more details about Prosight Management, LP portfolio as well as his latest detailed transactions.